Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2.

Liu Y, Nie T, Hou J, Long H, Zhang Z, Lei M, Xu Y, Wu W

Open source

DOI
10.1016/j.steroids.2023.109351
Published
2024 Feb
Container
Steroids
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.steroids.2023.109351,
  title = {Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2.},
  author = {Liu Y and Nie T and Hou J and Long H and Zhang Z and Lei M and Xu Y and Wu W},
  year = {2024},
  journal = {Steroids},
  doi = {10.1016/j.steroids.2023.109351},
  url = {https://doi.org/10.1016/j.steroids.2023.109351}
}

RIS

TY  - JOUR
TI  - Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2.
AU  - Liu Y
AU  - Nie T
AU  - Hou J
AU  - Long H
AU  - Zhang Z
AU  - Lei M
AU  - Xu Y
AU  - Wu W
PY  - 2024
JO  - Steroids
DO  - 10.1016/j.steroids.2023.109351
UR  - https://doi.org/10.1016/j.steroids.2023.109351
ER  -

APA

Y, L., T, N., J, H., H, L., Z, Z., M, L., Y, X., & W, W. (2024). Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2.. Steroids. https://doi.org/10.1016/j.steroids.2023.109351

Source records